A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to allow patients to receive VELCADE™ (bortezomib) for Injection who experienced progressive disease(PD) while receiving high-dose dexamethasone from the M34101-039 study.
Epistemonikos ID: b6c66172df0df38dd447e7937168f8fceac778b5
First added on: May 04, 2024